Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 345 entries
Sorted by: Best Match Show Resources per page
Pelatihan Perancangan Pembelajaran Abad-21 Melalui Pembelajaran Terintegrasi STEM Bagi Guru Sekolah Dasar

STEM training programs

Annisa M, Asrani A.
GSID: O7q404v5ClMJ
M Annisa, A Asrani, SR Salima… - J-ABDIPAMAS …, 2023 - ejurnal.ikippgribojonegoro.ac.id

… This program is in the form of training … service training went smoothly, this was marked by the attention and interactive questions and answers during the activity. The result of this training …

Cite
Annisa, M., Asrani, A., Salima, S. R., Handayani, M., & Norhayati, L. (2023). Pelatihan Perancangan Pembelajaran Abad-21 Melalui Pembelajaran Terintegrasi STEM Bagi Guru Sekolah Dasar. J-ABDIPAMAS (Jurnal Pengabdian Kepada Masyarakat), 7(1), 197-206.
Annisa, Muhsinah, et al. "Pelatihan Perancangan Pembelajaran Abad-21 Melalui Pembelajaran Terintegrasi STEM Bagi Guru Sekolah Dasar." J-ABDIPAMAS (Jurnal Pengabdian Kepada Masyarakat) 7.1 (2023): 197-206.
Copy Download .nbib Format: MLA
Focal treatment for genetic disorders (a fairy tale or a true story?).

International cardiovascular research journal

Nikoo MH, Jorat MV, Aslani A.
PMID: 25614854
Int Cardiovasc Res J. 2014 Dec;8(4):137-8. Epub 2014 Dec 01.

No abstract available.

Cite
Nikoo MH, Jorat MV, Aslani A. Focal treatment for genetic disorders (a fairy tale or a true story?). Int Cardiovasc Res J. 2014;8(4):137-8
Nikoo, M. H., Jorat, M. V., & Aslani, A. (2014). Focal treatment for genetic disorders (a fairy tale or a true story?). International cardiovascular research journal, 8(4), 137-8.
Nikoo, Mohamad Hossein, et al. "Focal treatment for genetic disorders (a fairy tale or a true story?)." International cardiovascular research journal vol. 8,4 (2014): 137-8.
Nikoo MH, Jorat MV, Aslani A. Focal treatment for genetic disorders (a fairy tale or a true story?). Int Cardiovasc Res J. 2014 Dec;8(4):137-8. Epub 2014 Dec 01. PMID: 25614854; PMCID: PMC4302498.
Copy Download .nbib Format: NLM
PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort.

Thrombosis research

Mancuso A, Vedovati MC, Pierpaoli L, Paliani U, Conti S, Filippucci E, Ascani A, Radicchia S, Galeotti G, Agnelli G, Becattini C.
PMID: 27161728
Thromb Res. 2016 Apr;140:S191. doi: 10.1016/S0049-3848(16)30173-6. Epub 2016 Apr 08.

INTRODUCTION: Cancer associated thrombosis (CAT) has an increased risk of recurrent venous thromboembolism (VTE). Type, stage of cancer and chemotherapy (CHT) influence thromboembolic risk. The use of novel oral anticoagulants (NOACs) is controversial in patients with CAT.AIM: The aim...

Cite
Mancuso A, Vedovati MC, Pierpaoli L, et al. PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort. Thromb Res. 2016;140:S191doi: 10.1016/S0049-3848(16)30173-6.
Mancuso, A., Vedovati, M. C., Pierpaoli, L., Paliani, U., Conti, S., Filippucci, E., Ascani, A., Radicchia, S., Galeotti, G., Agnelli, G., & Becattini, C. (2016). PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort. Thrombosis research, 140S191. https://doi.org/10.1016/S0049-3848(16)30173-6
Mancuso, A, et al. "PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort." Thrombosis research vol. 140 (2016): S191. doi: https://doi.org/10.1016/S0049-3848(16)30173-6
Mancuso A, Vedovati MC, Pierpaoli L, Paliani U, Conti S, Filippucci E, Ascani A, Radicchia S, Galeotti G, Agnelli G, Becattini C. PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort. Thromb Res. 2016 Apr;140:S191. doi: 10.1016/S0049-3848(16)30173-6. Epub 2016 Apr 08. PMID: 27161728.
Copy Download .nbib Format: NLM
Crystal structure of strontium dinickel iron orthophosphate.

Acta crystallographica. Section E, Crystallographic communications

Ouaatta S, Assani A, Saadi M, El Ammari L.
PMID: 26594419
Acta Crystallogr E Crystallogr Commun. 2015 Sep 26;71:1255-8. doi: 10.1107/S205698901501779X. eCollection 2015 Oct 01.

The title compound, SrNi2Fe(PO4)3, synthesized by solid-state reaction, crystallizes in an ordered variant of the α-CrPO4 structure. In the asymmetric unit, two O atoms are in general positions, whereas all others atoms are in special positions of the space...

Cite
Ouaatta S, Assani A, Saadi M, et al. Crystal structure of strontium dinickel iron orthophosphate. Acta Crystallogr E Crystallogr Commun. 2015;71:1255-8doi: 10.1107/S205698901501779X.
Ouaatta, S., Assani, A., Saadi, M., & El Ammari, L. (2015). Crystal structure of strontium dinickel iron orthophosphate. Acta crystallographica. Section E, Crystallographic communications, 711255-8. https://doi.org/10.1107/S205698901501779X
Ouaatta, Said, et al. "Crystal structure of strontium dinickel iron orthophosphate." Acta crystallographica. Section E, Crystallographic communications vol. 71 (2015): 1255-8. doi: https://doi.org/10.1107/S205698901501779X
Ouaatta S, Assani A, Saadi M, El Ammari L. Crystal structure of strontium dinickel iron orthophosphate. Acta Crystallogr E Crystallogr Commun. 2015 Sep 26;71:1255-8. doi: 10.1107/S205698901501779X. eCollection 2015 Oct 01. PMID: 26594419; PMCID: PMC4647370.
Copy Download .nbib Format: NLM
Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases.

Oncology letters

Kawaguchi T, Nakano M, Satani M, Sumie S, Yamada S, Amano K, Kuromatsu R, Sata M.
PMID: 24932302
Oncol Lett. 2014 Jun;7(6):2130-2134. doi: 10.3892/ol.2014.1976. Epub 2014 Mar 14.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that increases platelet counts in patients with idiopathic thrombocytopenic purpura and in patients with liver cirrhosis. When cirrhotic patients with thrombocytopenia undergo elective invasive procedures, eltrombopag treatment reduces the requirement for...

Cite
Kawaguchi T, Nakano M, Satani M, et al. Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases. Oncol Lett. 2014;7(6):2130-2134doi: 10.3892/ol.2014.1976.
Kawaguchi, T., Nakano, M., Satani, M., Sumie, S., Yamada, S., Amano, K., Kuromatsu, R., & Sata, M. (2014). Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases. Oncology letters, 7(6), 2130-2134. https://doi.org/10.3892/ol.2014.1976
Kawaguchi, Takumi, et al. "Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases." Oncology letters vol. 7,6 (2014): 2130-2134. doi: https://doi.org/10.3892/ol.2014.1976
Kawaguchi T, Nakano M, Satani M, Sumie S, Yamada S, Amano K, Kuromatsu R, Sata M. Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases. Oncol Lett. 2014 Jun;7(6):2130-2134. doi: 10.3892/ol.2014.1976. Epub 2014 Mar 14. PMID: 24932302; PMCID: PMC4049767.
Copy Download .nbib Format: NLM
"CHARGE-like presentation, craniosynostosis and mild Mowat-Wilson Syndrome diagnosed by recognition of the distinctive facial gestalt in a cohort of 28 new cases" American Journal of Medical Genetics Part A. 164:2557-2566, 2014.

American journal of medical genetics. Part A

Wenger TL, Harr M, Ricciardi S, Bhoj E, Santani A, Adam MP, Barnett SS, Ganetzky R, McDonald-McGinn DM, Battaglia D, Bigoni S, Selicorni A, Sorge G, Monica MD, Mari F, Andreucci E, Romano S, Cocchi G, Savasta S, Malbora B, Marangi G, Garavelli L, Zollino M, Zackai EH.
PMID: 26097173
Am J Med Genet A. 2015 Jul;167(7):1682-3. doi: 10.1002/ajmg.a.36860. Epub 2015 May 05.

No abstract available.

Cite
Wenger TL, Harr M, Ricciardi S, et al. "CHARGE-like presentation, craniosynostosis and mild Mowat-Wilson Syndrome diagnosed by recognition of the distinctive facial gestalt in a cohort of 28 new cases" American Journal of Medical Genetics Part A. 164:2557-2566, 2014. Am J Med Genet A. 2015;167(7):1682-3doi: 10.1002/ajmg.a.36860.
Wenger, T. L., Harr, M., Ricciardi, S., Bhoj, E., Santani, A., Adam, M. P., Barnett, S. S., Ganetzky, R., McDonald-McGinn, D. M., Battaglia, D., Bigoni, S., Selicorni, A., Sorge, G., Monica, M. D., Mari, F., Andreucci, E., Romano, S., Cocchi, G., Savasta, S., Malbora, B., Marangi, G., Garavelli, L., Zollino, M., & Zackai, E. H. (2015). "CHARGE-like presentation, craniosynostosis and mild Mowat-Wilson Syndrome diagnosed by recognition of the distinctive facial gestalt in a cohort of 28 new cases" American Journal of Medical Genetics Part A. 164:2557-2566, 2014. American journal of medical genetics. Part A, 167(7), 1682-3. https://doi.org/10.1002/ajmg.a.36860
Wenger, Tara L, et al. ""CHARGE-like presentation, craniosynostosis and mild Mowat-Wilson Syndrome diagnosed by recognition of the distinctive facial gestalt in a cohort of 28 new cases" American Journal of Medical Genetics Part A. 164:2557-2566, 2014." American journal of medical genetics. Part A vol. 167,7 (2015): 1682-3. doi: https://doi.org/10.1002/ajmg.a.36860
Wenger TL, Harr M, Ricciardi S, Bhoj E, Santani A, Adam MP, Barnett SS, Ganetzky R, McDonald-McGinn DM, Battaglia D, Bigoni S, Selicorni A, Sorge G, Monica MD, Mari F, Andreucci E, Romano S, Cocchi G, Savasta S, Malbora B, Marangi G, Garavelli L, Zollino M, Zackai EH. "CHARGE-like presentation, craniosynostosis and mild Mowat-Wilson Syndrome diagnosed by recognition of the distinctive facial gestalt in a cohort of 28 new cases" American Journal of Medical Genetics Part A. 164:2557-2566, 2014. Am J Med Genet A. 2015 Jul;167(7):1682-3. doi: 10.1002/ajmg.a.36860. Epub 2015 May 05. PMID: 26097173.
Copy Download .nbib Format: NLM
Cleft palate lateral synechia syndrome.

National journal of maxillofacial surgery

Sybil D, Sagtani A.
PMID: 24163560
Natl J Maxillofac Surg. 2013 Jan;4(1):87-9. doi: 10.4103/0975-5950.117876.

Cleft lip and palate are the most common congenital craniofacial anomaly in humans. The presence of oral synechia along with cleft palate is a rare syndrome. We encountered one case that had a cleft palate accompanied by congenital oral...

Cite
Sybil D, Sagtani A. Cleft palate lateral synechia syndrome. Natl J Maxillofac Surg. 2013;4(1):87-9doi: 10.4103/0975-5950.117876.
Sybil, D., & Sagtani, A. (2013). Cleft palate lateral synechia syndrome. National journal of maxillofacial surgery, 4(1), 87-9. https://doi.org/10.4103/0975-5950.117876
Sybil, Deborah, and Sagtani, Alok. "Cleft palate lateral synechia syndrome." National journal of maxillofacial surgery vol. 4,1 (2013): 87-9. doi: https://doi.org/10.4103/0975-5950.117876
Sybil D, Sagtani A. Cleft palate lateral synechia syndrome. Natl J Maxillofac Surg. 2013 Jan;4(1):87-9. doi: 10.4103/0975-5950.117876. PMID: 24163560; PMCID: PMC3800393.
Copy Download .nbib Format: NLM
Crystal structure of alluaudite-type NaMg3(HPO4)2(PO4).

Acta crystallographica. Section E, Crystallographic communications

Ould Saleck A, Assani A, Saadi M, Mercier C, Follet C, El Ammari L.
PMID: 26279874
Acta Crystallogr E Crystallogr Commun. 2015 Jun 20;71:813-5. doi: 10.1107/S205698901501155X. eCollection 2015 Jul 01.

The title compound, sodium trimagnesium bis-(hydrogen phosphate) phosphate, was obtained under hydro-thermal conditions. In the crystal, two types of [MgO6] octa-hedra, one with point group symmetry 2, share edges to build chains extending parallel to [10-1]. These chains are...

Cite
Ould Saleck A, Assani A, Saadi M, et al. Crystal structure of alluaudite-type NaMg3(HPO4)2(PO4). Acta Crystallogr E Crystallogr Commun. 2015;71:813-5doi: 10.1107/S205698901501155X.
Ould Saleck, A., Assani, A., Saadi, M., Mercier, C., Follet, C., & El Ammari, L. (2015). Crystal structure of alluaudite-type NaMg3(HPO4)2(PO4). Acta crystallographica. Section E, Crystallographic communications, 71813-5. https://doi.org/10.1107/S205698901501155X
Ould Saleck, Ahmed, et al. "Crystal structure of alluaudite-type NaMg3(HPO4)2(PO4)." Acta crystallographica. Section E, Crystallographic communications vol. 71 (2015): 813-5. doi: https://doi.org/10.1107/S205698901501155X
Ould Saleck A, Assani A, Saadi M, Mercier C, Follet C, El Ammari L. Crystal structure of alluaudite-type NaMg3(HPO4)2(PO4). Acta Crystallogr E Crystallogr Commun. 2015 Jun 20;71:813-5. doi: 10.1107/S205698901501155X. eCollection 2015 Jul 01. PMID: 26279874; PMCID: PMC4518993.
Copy Download .nbib Format: NLM
Conservative Management of Chronic TMJ Dislocation: An Old Technique Revived.

Journal of maxillofacial and oral surgery

Pradhan L, Jaisani MR, Sagtani A, Win A.
PMID: 25838707
J Maxillofac Oral Surg. 2015 Mar;14:267-70. doi: 10.1007/s12663-013-0476-9. Epub 2013 Feb 01.

A temporomadibular joint (TMJ) dislocation is a condition in which the mandibular condyle is displaced from its articulations and requires manipulation by another individual to return to its normal position. TMJ dislocation is subdivided into acute, chronic recurrent or...

Cite
Pradhan L, Jaisani MR, Sagtani A, et al. Conservative Management of Chronic TMJ Dislocation: An Old Technique Revived. J Maxillofac Oral Surg. 2013;14:267-70doi: 10.1007/s12663-013-0476-9.
Pradhan, L., Jaisani, M. R., Sagtani, A., & Win, A. (2015). Conservative Management of Chronic TMJ Dislocation: An Old Technique Revived. Journal of maxillofacial and oral surgery, 14267-70. https://doi.org/10.1007/s12663-013-0476-9
Pradhan, Leeza, et al. "Conservative Management of Chronic TMJ Dislocation: An Old Technique Revived." Journal of maxillofacial and oral surgery vol. 14 (2015): 267-70. doi: https://doi.org/10.1007/s12663-013-0476-9
Pradhan L, Jaisani MR, Sagtani A, Win A. Conservative Management of Chronic TMJ Dislocation: An Old Technique Revived. J Maxillofac Oral Surg. 2015 Mar;14:267-70. doi: 10.1007/s12663-013-0476-9. Epub 2013 Feb 01. PMID: 25838707; PMCID: PMC4379230.
Copy Download .nbib Format: NLM
Production, biodistribution, and dosimetry of (47)Sc-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid as a bone-seeking radiopharmaceutical.

Journal of medical physics

Fathi F, Moghaddam-Banaem L, Shamsaei M, Samani A, Maragheh MG.
PMID: 26500402
J Med Phys. 2015 Jul-Sep;40(3):156-64. doi: 10.4103/0971-6203.165078.

In this study 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid (DOTMP) was used as the polyaminophosphonic acid carrier ligand and the therapeutic potential of the bone seeking radiopharmaceutical (47)Sc-DOTMP was assessed by measuring its dosage-dependent skeletal uptake and then the absorbed radiation dose...

Cite
Fathi F, Moghaddam-Banaem L, Shamsaei M, et al. Production, biodistribution, and dosimetry of (47)Sc-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid as a bone-seeking radiopharmaceutical. J Med Phys. 2015;40(3):156-64doi: 10.4103/0971-6203.165078.
Fathi, F., Moghaddam-Banaem, L., Shamsaei, M., Samani, A., & Maragheh, M. G. (2015). Production, biodistribution, and dosimetry of (47)Sc-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid as a bone-seeking radiopharmaceutical. Journal of medical physics, 40(3), 156-64. https://doi.org/10.4103/0971-6203.165078
Fathi, Fatemeh, et al. "Production, biodistribution, and dosimetry of (47)Sc-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid as a bone-seeking radiopharmaceutical." Journal of medical physics vol. 40,3 (2015): 156-64. doi: https://doi.org/10.4103/0971-6203.165078
Fathi F, Moghaddam-Banaem L, Shamsaei M, Samani A, Maragheh MG. Production, biodistribution, and dosimetry of (47)Sc-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid as a bone-seeking radiopharmaceutical. J Med Phys. 2015 Jul-Sep;40(3):156-64. doi: 10.4103/0971-6203.165078. PMID: 26500402; PMCID: PMC4594385.
Copy Download .nbib Format: NLM
Balloon-shaped cystic subaortic membrane.

European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology

Aghasadeghi K, Aslani A, Amirghofran AA.
PMID: 19515704
Eur J Echocardiogr. 2009 Aug;10(6):804-5. doi: 10.1093/ejechocard/jep065. Epub 2009 Jun 10.

A 22-year-old man with a 4 month history of dyspnoea on exertion was referred for echocardiography. Transthoracic echocardiography revealed a balloon-shaped cystic mass (2 x 2 cm) attached to the left ventricular outflow tract (LVOT). Continuous-wave Doppler echocardiography showed...

Cite
Aghasadeghi K, Aslani A, Amirghofran AA. Balloon-shaped cystic subaortic membrane. Eur J Echocardiogr. 2009;10(6):804-5doi: 10.1093/ejechocard/jep065.
Aghasadeghi, K., Aslani, A., & Amirghofran, A. A. (2009). Balloon-shaped cystic subaortic membrane. European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 10(6), 804-5. https://doi.org/10.1093/ejechocard/jep065
Aghasadeghi, Kamran, et al. "Balloon-shaped cystic subaortic membrane." European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology vol. 10,6 (2009): 804-5. doi: https://doi.org/10.1093/ejechocard/jep065
Aghasadeghi K, Aslani A, Amirghofran AA. Balloon-shaped cystic subaortic membrane. Eur J Echocardiogr. 2009 Aug;10(6):804-5. doi: 10.1093/ejechocard/jep065. Epub 2009 Jun 10. PMID: 19515704.
Copy Download .nbib Format: NLM
BaMn(II) 2Mn(III)(PO4)3.

Acta crystallographica. Section E, Structure reports online

Assani A, Saadi M, Alhakmi G, Houmadi E, El Ammari L.
PMID: 24426979
Acta Crystallogr Sect E Struct Rep Online. 2013 Aug 23;69:i60. doi: 10.1107/S1600536813023106. eCollection 2013.

The title compound, barium trimanganese tris-(ortho-phosphate), was synthesized hydro-thermally. Its structure is isotypic with the lead and strontium analogues AMn(II) 2Mn(III)(PO4)3 (A = Pb, Sr). Except for two O atoms on general positions, all atoms are located on special...

Cite
Assani A, Saadi M, Alhakmi G, et al. BaMn(II) 2Mn(III)(PO4)3. Acta Crystallogr Sect E Struct Rep Online. 2013;69:i60doi: 10.1107/S1600536813023106.
Assani, A., Saadi, M., Alhakmi, G., Houmadi, E., & El Ammari, L. (2013). BaMn(II) 2Mn(III)(PO4)3. Acta crystallographica. Section E, Structure reports online, 69i60. https://doi.org/10.1107/S1600536813023106
Assani, Abderrazzak, et al. "BaMn(II) 2Mn(III)(PO4)3." Acta crystallographica. Section E, Structure reports online vol. 69 (2013): i60. doi: https://doi.org/10.1107/S1600536813023106
Assani A, Saadi M, Alhakmi G, Houmadi E, El Ammari L. BaMn(II) 2Mn(III)(PO4)3. Acta Crystallogr Sect E Struct Rep Online. 2013 Aug 23;69:i60. doi: 10.1107/S1600536813023106. eCollection 2013. PMID: 24426979; PMCID: PMC3884417.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 345 entries